Erik Wennerberg

3.6k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

Erik Wennerberg is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Erik Wennerberg has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 25 papers in Oncology and 9 papers in Physiology. Recurrent topics in Erik Wennerberg's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Erik Wennerberg is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Erik Wennerberg collaborates with scholars based in United States, Sweden and United Kingdom. Erik Wennerberg's co-authors include Sandra Demaria, Silvia C. Formenti, Andreas Lundqvist, Nils-Petter Rudqvist, Claire Vanpouille‐Box, Claire Lhuillier, Karsten A. Pilones, Veronika Kremer, Ryan Emerson and Xi Kathy Zhou and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Erik Wennerberg

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

2018 640 citations Silvia C. Formenti, Nils-Petter Rudqvist et al. Nature Medicine profile →

Peers

Countries citing papers authored by Erik Wennerberg

Since Specialization

Citations

This map shows the geographic impact of Erik Wennerberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wennerberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wennerberg more than expected).

Fields of papers citing papers by Erik Wennerberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wennerberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wennerberg. The network helps show where Erik Wennerberg may publish in the future.

Co-authorship network of co-authors of Erik Wennerberg

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Wennerberg. A scholar is included among the top collaborators of Erik Wennerberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Wennerberg. Erik Wennerberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer 2025 ·npj Breast Cancer ·Matthew J. Fenton, (unknown), Erik Wennerberg, Tom Lund, Andrew Tutt, Alan Melcher, Sandra Demaria, Navita Somaiah	0
2	Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), (unknown), Elena Provenzano, (unknown), Sara Lightowlers, (unknown), (unknown), Selvakumar Anbalagan, Tom Lund, Erik Wennerberg, Alan Melcher, Charlotte E. Coles, Ioannis Roxanis, Yinyin Yuan, Navita Somaiah	3
3	Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors 2023 ·Nature Communications ·Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier, Erik Wennerberg, Sheila Spada, Caroline Sheridan, Xi Kathy Zhou, Tuo Zhang, Silvia C. Formenti, Jennifer S. Sims, Alicia Alonso, Sandra Demaria	32
4	Tumour immune escape via P2X7 receptor signalling 2023 ·Frontiers in Immunology ·(unknown), Jorge Humberto Rodríguez-Quintero, María C. Maldifassi, Brendon M. Stiles, Erik Wennerberg	7
5	Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade 2021 ·Frontiers in Immunology ·Elizabeth Appleton, (unknown), Charleen Chan Wah Hak, (unknown), Anna Wilkins, Adel Samson, Masahiro Ono, Kevin J. Harrington, Alan Melcher, Erik Wennerberg	41
6	CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection 2020 ·Cancer Immunology Research ·Erik Wennerberg, Sheila Spada, Nils-Petter Rudqvist, Claire Lhuillier, Sylvia Gruber, Qiuying Chen, Fengli Zhang, Xi Kathy Zhou, Steven S. Gross, Silvia C. Formenti, Sandra Demaria	103
7	Exercise reduces immune suppression and breast cancer progression in a preclinical model 2020 ·Oncotarget ·Erik Wennerberg, Claire Lhuillier, Marissa Rybstein, (unknown), Nils-Petter Rudqvist, Graeme J. Koelwyn, Lee W. Jones, Sandra Demaria	84
8	Isolation of DNA from exosomes 2020 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Sheila Spada, Nils-Petter Rudqvist, Erik Wennerberg	10
9	Radiotherapy induces responses of lung cancer to CTLA-4 blockade breakdown → 2018 ·Nature Medicine ·Silvia C. Formenti, Nils-Petter Rudqvist, Encouse B. Golden, Benjamin T. Cooper, Erik Wennerberg, Claire Lhuillier, Claire Vanpouille‐Box, Kent Friedman, Lucas Ferrari de Andrade, Kai W. Wucherpfennig, Adriana Heguy, Naoko Imai, Sacha Gnjatic, Ryan Emerson, Xi Kathy Zhou, Tuo Zhang, Abraham Chachoua, Sandra Demaria	640
10	Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells 2017 ·Cancer Immunology Research ·Nils-Petter Rudqvist, Karsten A. Pilones, Claire Lhuillier, Erik Wennerberg, John-William Sidhom, Ryan Emerson, Harlan Robins, Jonathan P. Schneck, Silvia C. Formenti, Sandra Demaria	163
11	Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma 2017 ·Journal for ImmunoTherapy of Cancer ·Veronika Kremer, (unknown), (unknown), Christina Seitz, (unknown), Erik Wennerberg, Eugenia Colón, (unknown), Andreas Lundqvist	142
12	Barriers to Radiation-Induced In Situ Tumor Vaccination 2017 ·Frontiers in Immunology ·Erik Wennerberg, Claire Lhuillier, Claire Vanpouille‐Box, Karsten A. Pilones, Elena García-Martínez, Nils-Petter Rudqvist, Silvia C. Formenti, Sandra Demaria	152
13	Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control 2015 ·Journal for ImmunoTherapy of Cancer ·Andreas Lundqvist, Yumeng Mao, Xiaonan Zhang, Erik Wennerberg, Vincent van Hoef, Ola Larsson, Stig Linder, Rolf Kiessling	1
14	Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells 2014 ·Clinical Cancer Research ·Erik Wennerberg, Aline Pfefferle, Lars Ekblad, Yuya Yoshimoto, Veronika Kremer, Vitaliy O. Kaminskyy, C. Christofer Juhlin, Anders Höög, Inger Bodin, (unknown), Catharina Larsson, Jan Zedenius, Johan Wennerberg, Andreas Lundqvist	50
15	CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo 2014 ·Cancer Immunology Immunotherapy ·Erik Wennerberg, Veronika Kremer, Richard Childs, Andreas Lundqvist	152
16	A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells 2013 ·Cancer Immunology Immunotherapy ·Dhifaf Sarhan, Erik Wennerberg, Pádraig D’Arcy, (unknown), Stig Linder, Andreas Lundqvist	27
17	Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms 2013 ·Cancer Research ·Yumeng Mao, Isabel Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyházi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Masucci, Andreas Lundqvist, Rolf Kiessling	157
18	Doxorubicin sensitizes human tumor cells to NK cell‐ and T‐cell‐mediated killing by augmented TRAIL receptor signaling 2013 ·International Journal of Cancer ·Erik Wennerberg, Dhifaf Sarhan, Mattias Carlsten, Vitaliy O. Kaminskyy, Pádraig D’Arcy, Boris Zhivotovsky, Richard Childs, Andreas Lundqvist	49
19	Opposing consequences of signaling through EGF family members 2012 ·OncoImmunology ·Rolf Kiessling, Riki Okita, Dimitrios Mougiakakos, Yumeng Mao, Dhifaf Sarhan, Erik Wennerberg, Barbara Seliger, Andreas Lundqvist, Kousaku Mimura, Koji Kono	2
20	HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines 2012 ·The Journal of Immunology ·Riki Okita, Dimitrios Mougiakakos, Takashi Ando, Yumeng Mao, Dhifaf Sarhan, Erik Wennerberg, Barbara Seliger, Andreas Lundqvist, Kousaku Mimura, Rolf Kiessling	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact